The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years

Kristina Jenei; Daniel E Meyers; Vinay Prasad

doi:10.1001/jamaoncol.2021.3686

The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years

JAMA Oncol. 2021 Oct 1;7(10):1569-1570. doi: 10.1001/jamaoncol.2021.3686.

Authors

Kristina Jenei¹, Daniel E Meyers², Vinay Prasad³

Affiliations

¹ School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco.

Abstract

This cohort study reviews enrollment patterns of completed cancer drug trials over the past 20 years to compare sex-specific trial participation with current cancer incidence rates.

MeSH terms

Female
Humans
Medical Oncology*
Neoplasms* / drug therapy